Oren, I've often wondered about the feverish issue as well-does it make sense to treat it or not. In my due diligence on VBLT, in the phase II trial for rGBM, those with fever were treated with Tylenol, ect... So, treating the febrile response should not impact the trial.
Market Data 
Markets 
AI
